Lovastatin
- Product NDC
- 70934-750
- 11-digit product format
- 709340750
- Labeler code
- 70934
- Product ID
- 70934-750_a9c8a9f9-a167-1fb8-e053-2995a90a716a
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Lovastatin
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Denton Pharma, Inc. dba Northwind Pharmaceuticals
- Application
- ANDA075551
- Marketing category
- ANDA
- Marketing start
- 2020-05-28
- Marketing end
- 0000-00-00
- Substance
- LOVASTATIN
- Active strength
- 20 mg/1
- Pharmacologic classes
- HMG-CoA Reductase Inhibitor [EPC],Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
Related UNII Ingredients
| UNII | Preferred term | Registry number | Matched term |
|---|
| 9LHU78OQFD | LOVASTATIN | 75330-75-5 | LOVASTATIN |
Packages
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 70934-750-30 | 70934075030 | 30 TABLET in 1 BOTTLE, PLASTIC (70934-750-30) | 30 tablet | 2021-04-16 | 0000-00-00 | No | No | Current |
| 70934-750-90 | 70934075090 | 90 TABLET in 1 BOTTLE, PLASTIC (70934-750-90) | 90 tablet | 2020-05-28 | 0000-00-00 | No | No | Current |